Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
SPDR S&P Pharmaceuticals ETF (XPH) and SPDR S&P Health Care Equipment ETF (XHE) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. Both XPH and XHE have the same Total Expense Ratio (TER) of 0.35%. XPH is down -1.12% year-to-date (YTD) with +$88M in YTD flows. XHE performs worse with -6.79% YTD performance, and -$4M in YTD flows. Run a side-by-side ETF comparison of XPH and XHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XPH XHE | -3.45%-4.63% | -1.36%-8.38% | -1.12%-6.79% | +29.22%-1.88% | +42.98%-7.27% | +9.16%-31.62% |
| Flows | XPH XHE | +$12M- | +$95M-$7M | +$88M-$4M | +$111M-$44M | +$48M-$295M | +$36M-$430M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XPH XHE | +20.33%+18.94% | +23.08%+23.53% | +19.01%+21.07% | +20.26%+24.17% |
| Max drawdown | XPH XHE | -5.97%-12.38% | -17.10%-14.34% | -23.45%-32.63% | -33.10%-49.90% |
| Max drawdown duration | XPH XHE | 14d62d | 140d241d | 322d1053d | 1706d1651d |
XPH | XHE | |
Last sale 3/12/2026 at 1:34 PM | $54.05 | $82.04 |
| Previous close 03/11/2026 | $55.49 | $81.73 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
XPH | XHE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
XPH | XHE | |
|---|---|---|
| Last price | $54.05 | $82.04 |
| 1D performance | -2.60% | +0.38% |
| AuM | $313.37 M | $139.64 M |
| E/R | 0.35% | 0.35% |
XPH | XHE | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | SPDR | SPDR |
| Benchmark | S&P Pharmaceuticals Select Industry Index | S&P Health Care Equipment Select Industry Index |
| N° of holdings | 49 | 61 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 19, 2006 | January 26, 2011 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
